MTOR and breast carcinoma: demonstrated that HINT3 inhibits the activation of the PTEN/AKT/mTOR signaling pathway and suppresses the proliferation, growth, migration, and tumorigenicity of MCF‐7 and MDA‐MB‐231 breast cancer cells.[11] Similarly, Jung et al.